Celsius (NASDAQ:CELH) Price Target Raised to $56.00 at B. Riley

Key Points

• B. Riley has raised its price target for Celsius (NASDAQ:CELH) from $52.00 to $56.00, indicating a potential upside of 8.72% from the current stock price.
• Other analysts have also shown bullish sentiment, with UBS increasing its target to $57.00 and Citigroup setting a target of $55.00, while the consensus rating remains a Moderate Buy.
• Celsius reported significant year-over-year growth, achieving a revenue of $739.30 million and an EPS of $0.47, exceeding consensus estimates by $0.24.

Celsius (NASDAQ:CELH - Get Free Report) had its price target increased by equities research analysts at B. Riley from $52.00 to $56.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has a "buy" rating on the stock. B. Riley's price target points to a potential upside of 7.80% from the stock's current price. B. Riley also issued estimates for Celsius' Q3 2025 earnings at $0.21 EPS, FY2025 earnings at $0.83 EPS, FY2026 earnings at $1.28 EPS and FY2027 earnings at $1.77 EPS.

Several other research analysts have also issued reports on CELH. Piper Sandler raised their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 4th. UBS Group lifted their price objective on Celsius from $49.00 to $57.00 and gave the stock a "buy" rating in a research report on Thursday, July 17th. Truist Financial lifted their price objective on Celsius from $50.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, July 14th. Citigroup assumed coverage on Celsius in a research report on Wednesday, July 23rd. They issued a "buy" rating and a $55.00 price objective for the company. Finally, TD Cowen raised Celsius from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $37.00 to $55.00 in a research report on Monday, June 16th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $51.72.

Celsius Price Performance

Shares of CELH stock traded up $1.83 during trading hours on Friday, reaching $51.95. The company's stock had a trading volume of 10,291,968 shares, compared to its average volume of 6,108,101. The firm's 50 day simple moving average is $44.51 and its 200-day simple moving average is $36.13. The company has a market capitalization of $13.39 billion, a price-to-earnings ratio of 140.41, a PEG ratio of 1.81 and a beta of 1.40. Celsius has a fifty-two week low of $21.10 and a fifty-two week high of $53.85. The company has a quick ratio of 3.04, a current ratio of 2.11 and a debt-to-equity ratio of 0.68.

Celsius (NASDAQ:CELH - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.24. Celsius had a return on equity of 36.88% and a net margin of 7.91%. The firm had revenue of $739.30 million for the quarter, compared to the consensus estimate of $632.13 million. During the same quarter last year, the business posted $0.28 EPS. The company's revenue was up 83.9% compared to the same quarter last year. Sell-side analysts forecast that Celsius will post 0.89 earnings per share for the current year.

Insider Activity at Celsius

In related news, major shareholder William H. Milmoe sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the sale, the insider owned 17,717,770 shares in the company, valued at approximately $841,594,075. This trade represents a 0.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Deborah Desantis sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, July 31st. The stock was sold at an average price of $47.50, for a total transaction of $4,750,000.00. Following the completion of the sale, the insider owned 17,717,770 shares in the company, valued at $841,594,075. This represents a 0.56% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,106,141 shares of company stock valued at $51,985,705 over the last 90 days. Corporate insiders own 2.55% of the company's stock.

Institutional Investors Weigh In On Celsius

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Alliancebernstein L.P. boosted its holdings in Celsius by 26.3% in the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock worth $642,769,000 after purchasing an additional 3,753,055 shares during the last quarter. Alyeska Investment Group L.P. boosted its stake in shares of Celsius by 60.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after acquiring an additional 2,591,345 shares during the last quarter. FMR LLC boosted its stake in shares of Celsius by 64.2% during the 4th quarter. FMR LLC now owns 4,055,148 shares of the company's stock worth $106,813,000 after acquiring an additional 1,585,839 shares during the last quarter. Champlain Investment Partners LLC purchased a new position in shares of Celsius during the 4th quarter worth $85,068,000. Finally, Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Celsius by 12.5% during the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,682,225 shares of the company's stock worth $70,650,000 after acquiring an additional 298,565 shares during the last quarter. Hedge funds and other institutional investors own 60.95% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.